Skip to main content
Top
Published in: Journal of Nuclear Cardiology 6/2009

01-12-2009 | Original Article

The study of myocardial perfusion and coronary anatomy imaging roles in CAD (SPARC): design, rationale, and baseline patient characteristics of a prospective, multicenter observational registry comparing PET, SPECT, and CTA for resource utilization and clinical outcomes

Authors: Rory Hachamovitch, MD, MSc, James R. Johnson, PhD, Mark A. Hlatky, MD, FACC, Lisa Cantagallo, MBA, Barbara H. Johnson, MS, RPh, Martha Coughlan, Jon Hainer, Jeselle Gierbolini, Marcelo F. Di Carli, MD, for the SPARC Investigators

Published in: Journal of Nuclear Cardiology | Issue 6/2009

Login to get access

Abstract

Objectives

To design a multicenter study comparing the prognostic value and post-test resource utilization of PET, CT Coronary Angiography (CTA), and SPECT in clinical practice.

Background

Although PET, CTA, and SPECT are widely used, their relative clinical- and cost-effectiveness are undefined.

Methods

The Study of Myocardial Perfusion and Coronary Anatomy Imaging Roles in CAD (SPARC) is a prospective, multicenter, observational registry that has enrolled 3019 patients undergoing clinically referred SPECT, PET, and CTA with the goal of comparing post-test resource utilization and comparative prognostic value. Resource utilization assessment will enroll intermediate-high likelihood patients without prior CAD, while prognostic assessment will include both these patients and patients with prior CAD. Secondary analyses include assessments of diagnostic accuracy, cost, and referral to revascularization. Sites recruited into at least two of the three imaging arms. Except for semi-quantitative interpretation, site protocols will be used for all imaging studies and images forwarded to an image repository. Follow-up for catheterization, revascularization, cardiac death, myocardial infarction, all-cause death and medication use changes will be performed at 90-day, 1, and 2 years. Standard statistical methods will be used to risk-adjust results within and between study arms. SPARC will have >85% power (two-sided test, α = 0.01) to detect a 5% catheterization rate difference at 90 days between the three arms and >90% power to detect a 2% difference in cardiac death, or nonfatal MI within 2 years of the index test.

Conclusions

SPARC will be the first study comparing outcomes and resource utilization between SPECT, PET, and CTA in daily practice. In addition, the study design offers insights into inter-site and geographic differences in referral patterns and resource utilization.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-68.CrossRefPubMed Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-68.CrossRefPubMed
2.
go back to reference Hachamovitch R, Beller GA. Critical review of imaging approaches for diagnosis and prognosis of CAD. In: Di Carli MF, Kwong R, editors. Novel techniques for imaging the heart: Cardiac MR and CT. Oxford: Blackwell Publishing; 2008. Hachamovitch R, Beller GA. Critical review of imaging approaches for diagnosis and prognosis of CAD. In: Di Carli MF, Kwong R, editors. Novel techniques for imaging the heart: Cardiac MR and CT. Oxford: Blackwell Publishing; 2008.
3.
go back to reference Di Carli MF, Hachamovitch R. New technology for non-invasive evaluation of coronary artery disease. Circulation 2007;115:1464-80.CrossRefPubMed Di Carli MF, Hachamovitch R. New technology for non-invasive evaluation of coronary artery disease. Circulation 2007;115:1464-80.CrossRefPubMed
4.
go back to reference Redberg RF. Evidence, appropriateness, and technology assessment in cardiology: A case study of computed tomography. Health Affairs 2007;26:89-95.CrossRef Redberg RF. Evidence, appropriateness, and technology assessment in cardiology: A case study of computed tomography. Health Affairs 2007;26:89-95.CrossRef
5.
go back to reference Hachamovitch R, Di Carli MF. Contemporary reviews in cardiovascular medicine: Methods and limitations of assessing new noninvasive tests II. Outcomes-based validation and reliability assessment of noninvasive testing. Circulation 2008;117:2793-801.CrossRefPubMed Hachamovitch R, Di Carli MF. Contemporary reviews in cardiovascular medicine: Methods and limitations of assessing new noninvasive tests II. Outcomes-based validation and reliability assessment of noninvasive testing. Circulation 2008;117:2793-801.CrossRefPubMed
6.
go back to reference Berman DS, Hachamovitch R, Shaw LJ, Germano G, Hayes S. Nuclear cardiology. In: AR Fuster V, King S, O’Rourke RA, Wellens HJJ, editors. Hurst’s the heart. New York: McGraw-Hill; 2004. p. 525-65. Berman DS, Hachamovitch R, Shaw LJ, Germano G, Hayes S. Nuclear cardiology. In: AR Fuster V, King S, O’Rourke RA, Wellens HJJ, editors. Hurst’s the heart. New York: McGraw-Hill; 2004. p. 525-65.
7.
go back to reference Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.CrossRefPubMed Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.CrossRefPubMed
8.
go back to reference Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA Guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 1999;33:1756-824.CrossRefPubMed Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA Guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 1999;33:1756-824.CrossRefPubMed
9.
go back to reference Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.CrossRefPubMed Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.CrossRefPubMed
10.
go back to reference Lachin JM. Sample size determinations for R × C comparative trials. Biometrics 1977;33:315-24.CrossRefPubMed Lachin JM. Sample size determinations for R × C comparative trials. Biometrics 1977;33:315-24.CrossRefPubMed
11.
go back to reference Kelsey JL, Whittemore AS, Evans AS, Thompson WD. Methods in observational epidemiology. 2nd ed. New York: Oxford University Press; 1996. Kelsey JL, Whittemore AS, Evans AS, Thompson WD. Methods in observational epidemiology. 2nd ed. New York: Oxford University Press; 1996.
12.
go back to reference Selvin S. Statistical analysis of epidemiologic data. New York, NY: Oxford University Press; 2004.CrossRef Selvin S. Statistical analysis of epidemiologic data. New York, NY: Oxford University Press; 2004.CrossRef
13.
go back to reference Newman SC. Biostatistical methods in epidemiology. New York: Wiley; 2001. Newman SC. Biostatistical methods in epidemiology. New York: Wiley; 2001.
14.
go back to reference Shaw LJ, Narula J. Bridging the detection gap chasm of risk: Where can computed tomography angiography take us? J Am Coll Cardiol Img 2009;2:524-6. Shaw LJ, Narula J. Bridging the detection gap chasm of risk: Where can computed tomography angiography take us? J Am Coll Cardiol Img 2009;2:524-6.
15.
go back to reference Earls JP, Berman E, Urban BA, et al. Prospectively gated transverse coronary CT angiography versus retrospectively gated helical technique: Improved image quality and reduced radiation dose. Radiology 2008;246:742-53.CrossRefPubMed Earls JP, Berman E, Urban BA, et al. Prospectively gated transverse coronary CT angiography versus retrospectively gated helical technique: Improved image quality and reduced radiation dose. Radiology 2008;246:742-53.CrossRefPubMed
Metadata
Title
The study of myocardial perfusion and coronary anatomy imaging roles in CAD (SPARC): design, rationale, and baseline patient characteristics of a prospective, multicenter observational registry comparing PET, SPECT, and CTA for resource utilization and clinical outcomes
Authors
Rory Hachamovitch, MD, MSc
James R. Johnson, PhD
Mark A. Hlatky, MD, FACC
Lisa Cantagallo, MBA
Barbara H. Johnson, MS, RPh
Martha Coughlan
Jon Hainer
Jeselle Gierbolini
Marcelo F. Di Carli, MD
for the SPARC Investigators
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 6/2009
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-009-9140-7

Other articles of this Issue 6/2009

Journal of Nuclear Cardiology 6/2009 Go to the issue